D. Bonney

A. T. van der Ploeg, P. V. van Hasselt, F. Wijburg, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

G. Lucchini, A. Hackshaw, P. Veys, 2019, Nature Medicine.

Simultaneous Targeting of CD19 and CD22: Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

P. Veys, R. Hough, A. Vora, 2018, Blood.

A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD).

M. Fleming, P. Chakraborty, R. Klaassen, 2013, Blood.

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).

Erin K. Kennedy, M. Fleming, Ashley Lau, 2014, Blood.

Blinatumomab for Infant Acute Lymphoblastic Leukaemia.

D. O’Connor, J. Bartram, S. Samarasinghe, 2020, Blood.

The role of immunotherapy in relapse/refractory precursor‐B acute lymphoblastic leukaemia: real‐life UK/Ireland experience in children and young adults

A. Vora, J. Moppett, P. Amrolia, 2020, British journal of haematology.

immunodeficiency, periodic fevers, and developmental delay (SIFD) A novel syndrome of congenital sideroblastic anemia, B-cell

M. Fleming, P. Chakraborty, R. Klaassen, 2013 .

B-cell depletion abrogates immune mediated cytopenia and rejection of cord blood transplantation in Hurler syndrome

K. Poulton, P. V. van Hasselt, D. Bonney, 2021, Bone Marrow Transplantation.

Immune cytopenia post-cord transplant in Hurler syndrome is a forme fruste of graft rejection.

S. Stanworth, K. Poulton, D. Bonney, 2019, Blood advances.

UK experience of unrelated cord blood transplantation in paediatric patients

A. Gennery, J. Snowden, P. Veys, 2016, British journal of haematology.

Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome

P. Orchard, K. Poulton, T. Lund, 2017 .

Burden of adenoviraemia predicts survival in paediatric recipients of allogeneic haematopoietic stem cell transplant.

D. Bonney, M. Guiver, R. Wynn, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Molecular monitoring of adenovirus reactivation in faeces after haematopoietic stem-cell transplantation to predict systemic infection: a retrospective cohort study.

D. Bonney, M. Guiver, R. Wynn, 2018, The Lancet. Haematology.

Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia.

K. Gilmour, K. Poulton, D. Bonney, 2020, Blood advances.

Sustained response to intrathecal rituximab in EBV associated Post‐transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant

A. Shabani, A. Kelsey, I. Hughes, 2012, Pediatric blood & cancer.

Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia.

J. Wagner, R. Krance, P. Veys, 2012, Blood.

Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease

W. Newman, A. Broomfield, B. Bigger, 2021, Orphanet Journal of Rare Diseases.

The Changing Patterns of Graft Failure in MPS1H, Hurler Syndrome: A Review of 30-Years Experience

P. Orchard, T. Lund, D. Bonney, 2016 .

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

G. Lucchini, P. Veys, F. Farzaneh, 2021, Nature Medicine.

Complications of Reduced Intensity Conditioning HSCT for XIAP Deficiency (Alloimmune Cytopenias and HLH) Successfully Managed With Donor Lymphocyte Infusion

D. Bonney, S. Hughes, R. Wynn, 2015, Journal of pediatric hematology/oncology.

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

G. Lucchini, A. Hackshaw, P. Veys, 2019, Nature Medicine.

Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy Targeting CD19 and CD22, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

P. Veys, R. Hough, A. Vora, 2019, Blood.

Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1.

D. Bonney, R. Wynn, D. Wiseman, 2012, Journal of pediatric hematology/oncology.

Granulocyte transfusion during cord blood transplant for relapsed, refractory AML is associated with massive CD8+ T‐cell expansion, significant cytokine release syndrome and induction of disease remission

S. Stanworth, K. Poulton, R. Dillon, 2023, British journal of haematology.

Successful allogeneic bone marrow transplant for Niemann–Pick disease type C2 is likely to be associated with a severe ‘graft versus substrate’ effect

A. Shabani, B. Bigger, J. E. Wraith, 2010, Journal of Inherited Metabolic Disease.

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma

E. Klopocki, A. Whetton, J. Dorsman, 2012, Familial Cancer.

Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin

D. Bonney, A. Turner, A. Will, 2009, British journal of haematology.

Successful Curative Therapy With Rituximab and Allogeneic Haematopoietic Stem Cell Transplantation for MALT Lymphoma Associated With STK4‐Mutated CD4+ Lymphocytopenia

D. Bonney, S. Hughes, R. Wynn, 2016, Pediatric blood & cancer.

A decade of excellent transplant survival in children with inherited metabolic diseases: A report from a single metabolic transplant centre in Europe

Helena, Jones, K. Poulton, 2019, BLOOD CELL THERAPY / The official journal of APBMT.

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

G. Lucchini, A. Hackshaw, P. Veys, 2019, Blood.

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL

A. Enshaei, S. Samarasinghe, J. Moppett, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma

E. Klopocki, A. Whetton, J. Dorsman, 2012, Familial Cancer.

Alemtuzumab, dual GVHD prophylaxis, and lower CD3+ T cell doses equalize rates of acute and chronic GVHD among pediatric patients receiving allogeneic HSCT with matched unrelated donor PBSC or bone marrow grafts.

J. Moppett, P. Amrolia, M. Slatter, 2023, Transplantation and cellular therapy.